Llwytho...
Denosumab for management of severe hypercalcemia in primary hyperparathyroidism
Hypercalcemic crisis is a severe but rare complication of primary hyperparathyroidism (PHPT), and data on denosumab treatment of patients with this disease is still very limited. The aim of this paper is to investigate the hypocalcemic effect of denosumab in PHPT patients with severe hypercalcemia w...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Endocr Connect |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Bioscientifica Ltd
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7707828/ https://ncbi.nlm.nih.gov/pubmed/33112830 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-20-0380 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|